吉林敖東(000623.SZ)目前經營的主業範圍不涉及AI相關業務
格隆匯3月19日丨吉林敖東(000623.SZ)在投資者互動平台表示,公司目前經營的主業範圍不涉及AI相關業務,公司積極關注AI與醫療深度融合帶來的產業變革。公司聚焦醫藥主業發展,在中藥配方顆粒等重點項目建設上,配備智能控制系統,生產設備和關鍵環節網絡全覆蓋,實現生產質控信息化、數字化、智能化,以“智能化+工業化”驅動全產業鏈升級,以技術創新夯實核心競爭力,踐行高質量發展使命。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.